AZothBio
AZothBio is a company specializing in the development of new drugs and drug delivery systems based on an artificial intelligence platform. Their proprietary AI platform, iSTAs, comprises MoliSTA for 3D molecular structure representation of drug candidates, DDiSTA for predicting cell permeability and generating new structures, and ArchiSTA for integrated data management. They collaborate with various pharmaceutical and biotech companies and are independently developing small molecule therapeutics for autoimmune diseases and cancer, as well as cell-permeable peptide drug delivery systems. These drug delivery systems are designed to selectively deliver nucleic acids or small molecules to intracellular organelles. AZothBio aims to expand its applications to immune disease treatments, gene therapy, and inflammatory treatments. Utilizing their AI platform significantly reduces the cost and time required for new drug development, enabling faster decision-making and accurate prediction of drug efficacy.
AZothBio
AZothBio is a company specializing in the development of new drugs and drug delivery systems based on an artificial intelligence platform. Their proprietary AI platform, iSTAs, comprises MoliSTA for 3D molecular structure representation of drug candidates, DDiSTA for predicting cell permeability and generating new structures, and ArchiSTA for integrated data management. They collaborate with various pharmaceutical and biotech companies and are independently developing small molecule therapeutics for autoimmune diseases and cancer, as well as cell-permeable peptide drug delivery systems. These drug delivery systems are designed to selectively deliver nucleic acids or small molecules to intracellular organelles. AZothBio aims to expand its applications to immune disease treatments, gene therapy, and inflammatory treatments. Utilizing their AI platform significantly reduces the cost and time required for new drug development, enabling faster decision-making and accurate prediction of drug efficacy.